Enzo Biochem, a molecular diagnostics company, has introduced the ColonSentry blood-based risk stratification test to assess a patient's risk of having colorectal cancer. ColonSentry requires a small blood sample and utilizes RNA to ...
Tags: Enzo Biochem, ColonSentry blood-based risk stratification test